ArticleEClinicalMedicine2020

A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19.

Weihui Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.